he incidence and features of subclinical Cushing’s syndrome in women with polycystic ovaries
Journal Title: Міжнародний ендокринологічний журнал - Year 2017, Vol 13, Issue 3
Abstract
Background. The purpose of investigation is to study the incidence of subclinical Cushing’s syndrome in women with polycystic ovary syndrome (PCOS). Materials and methods. Under our supervision, there were 120 patients of fertile age with PCOS. The average age of patients was 25.5 ± 4.3 years. Twenty healthy women of corresponding age made a control group. The complex of researches, including clinical, biochemical, hormonal (luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin, estradiol, progesterone, dehydroepiandrostendion, 17-hydroxyprogesterone, anti-Mullerian hormone, insulin on day 14 of cycle), was performed in all patients, as well as ultrasonography of the uterus and ovaries with folliculometry in dynamics, and also magnetic resonance imaging and survey of patients. Results. Patients were divided into three groups: with primary PCOS (19 %), with secondary PCOS and obesity (74 %), with secondary PCOS and subclinical Cushing’s syndrome (7 %). In the first group of patients, a significant decrease of pituitary and ovarian hormones has been registered on the background of hyperandrogenemia. In the third group of patients, a significant decrease of pituitary hormones was also detected on the background of hyperandrogenemia. Conclusions. The most significant violations in the system of pituitary-ovarian function were found in the third group of patients with subclinical Cushing’s syndrome, at that, a significant decrease in the functional state of pituitary-gonadal system was marked, namely decline of LH, FSH, estradiol and progesterone on the background of hyperandrogenemia and hypercortisolemia. The incidence of subclinical Cushing’s syndrome among women with PCOS is 6.6 %. In future, it is necessary to monitor in dynamics the probability of recovery of fertility in all groups of patients with PCOS
Authors and Affiliations
Yu. M. Urmanova, Z. Yu. Khalimova, G. D. Narimova, H. R. Madaminova, M. B. Abduvahabova, D. A. Alieva, D. Sh. Holova, H. O. Alimukhamedova, M. M. Karimova, F. S. Hodjaeva, H. K. Nasirova, N. T. Rihsieva
Keywords
Related Articles
- EP ID EP212632
- DOI 10.22141/2224-0721.13.3.2017.104112
- Views 71
- Downloads 0
Hyperleptinemia as One of the Factors for Renal Dysfunction in Patients with Hypothyroidism
In order to study the features of renal function in patients with hypothyroidism we have examined 132 patients with primary hypothyroidism. The results showed that in patients with overt hypothyroidism there is renal dys...
Osteoporosis and Low-energy Hip Fractures as Complication of Various Endocrine Diseases (Literature Review)
The authors carried out the literature review on the problem of low-energy hip fractures. This pathology, as shown by the literature review, is at the crossroads of several disciplines — traumatology, endocrinology, card...
Hypertension as a Risk Factor for Diabetes Mellitus
The objective of the investigation — to study in the age aspect the prevalence of hypertension among men and women of urban and rural population as a risk factor for diabetes type 2. The total number of surveyed among th...
Autoimmune Polyendocrine Syndromes: Classification, Clinical Picture, Diagnosis, Treatment
Autoimmune polyendocrine syndromes are the actual problem of modern medicine, as include the development of several autoimmune endocrinopathies in the same patient, associated with autoimmune nonendocrine pathology. The...
Primary Adrenal Insufficiency: Diagnosis and Management (According to the 17th European Congress of Endocrinology, Dublin, Ireland 16–20 May, 2015)
Primary adrenal insufficiency (PAI, Addison’s disease) — treatable disease, remains potentially lethal. PAI is often detected in the state of adrenal crisis, and timely emergency treatment can prevent the death. To minim...